Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genelux (GNLX) Cash & Equivalents (2022 - 2025)

Genelux has reported Cash & Equivalents over the past 4 years, most recently at $5.3 million for Q4 2025.

  • Quarterly results put Cash & Equivalents at $5.3 million for Q4 2025, down 37.73% from a year ago — trailing twelve months through Dec 2025 was $5.3 million (down 37.73% YoY), and the annual figure for FY2025 was $5.3 million, down 37.73%.
  • Cash & Equivalents for Q4 2025 was $5.3 million at Genelux, up from $4.7 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for GNLX hit a ceiling of $34.5 million in Q3 2024 and a floor of $397000.0 in Q4 2022.
  • Median Cash & Equivalents over the past 4 years was $8.6 million (2024), compared with a mean of $14.5 million.
  • Biggest five-year swings in Cash & Equivalents: skyrocketed 1895.97% in 2023 and later tumbled 86.36% in 2025.
  • Genelux's Cash & Equivalents stood at $397000.0 in 2022, then skyrocketed by 1895.97% to $7.9 million in 2023, then rose by 8.09% to $8.6 million in 2024, then plummeted by 37.73% to $5.3 million in 2025.
  • The last three reported values for Cash & Equivalents were $5.3 million (Q4 2025), $4.7 million (Q3 2025), and $28.1 million (Q2 2025) per Business Quant data.